PDE4B inhibitor (Tetra Therapeutics) | m-entrepreneurship.com

Product Name :
PDE4B inhibitor (Tetra Therapeutics)

Search keywords :
PDE4B

drugId :
null

Target Vo:
Phosphodiesterase 4B

Target Vo Short Name :
PDE4B

Moa_Name:
Phosphodiesterase 4B inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Tetra Therapeutics Inc

Active Company_Name :
Tetra Therapeutics Inc

Active Indication_Name:
Alzheimer Disease

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
IRF3 Rabbit mAb Cancer
PDCD4 Rabbit mAb supplier
CBR1 Antibody (YA810): CBR1 Antibody (YA810) is a non-conjugated and Mouse origined monoclonal antibody about 30 kDa, targeting to CBR1 (2C9). It can be used for WB,ICC/IF assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts